Evaluation of GlcNAc-Configured Glycomimetics as Pharmacological Chaperones of NAGLU for the Treatment of Mucopolysaccharidosis IIIB.

Ballout N, Désiré J, Espejo-Mojica AJ, Niño-Traslaviña K, Sandoval D, Alméciga-Díaz CJ, Blériot Y, Ausseil J

DOI: 10.3390/biom16020313
Published: 2026 Feb 16
Container: Biomolecules
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/biom16020313,
  title = {Evaluation of GlcNAc-Configured Glycomimetics as Pharmacological Chaperones of NAGLU for the Treatment of Mucopolysaccharidosis IIIB.},
  author = {Ballout N and Désiré J and Espejo-Mojica AJ and Niño-Traslaviña K and Sandoval D and Alméciga-Díaz CJ and Blériot Y and Ausseil J},
  year = {2026},
  journal = {Biomolecules},
  doi = {10.3390/biom16020313},
  url = {https://doi.org/10.3390/biom16020313}
}

RIS

TY  - JOUR
TI  - Evaluation of GlcNAc-Configured Glycomimetics as Pharmacological Chaperones of NAGLU for the Treatment of Mucopolysaccharidosis IIIB.
AU  - Ballout N
AU  - Désiré J
AU  - Espejo-Mojica AJ
AU  - Niño-Traslaviña K
AU  - Sandoval D
AU  - Alméciga-Díaz CJ
AU  - Blériot Y
AU  - Ausseil J
PY  - 2026
JO  - Biomolecules
DO  - 10.3390/biom16020313
UR  - https://doi.org/10.3390/biom16020313
ER  -

APA

N, B., J, D., AJ, E., K, N., D, S., CJ, A., Y, B., & J, A. (2026). Evaluation of GlcNAc-Configured Glycomimetics as Pharmacological Chaperones of NAGLU for the Treatment of Mucopolysaccharidosis IIIB.. Biomolecules. https://doi.org/10.3390/biom16020313

Source records

pubmed · retrieved 2026-09-26T13:29:03.196Z